19.5.2021 16:15:00 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

The annual general meeting of Aqua Bio Technology ASA (the "Company") will be
held on 9 June 2021 at 10:00 (CEST) at Advokatfirmaet CLP DA, Sommerrogata
13-15, 0255 Oslo.

Attached is the notice of the annual general meeting together with attendance
and proxy form, the board of directors' statement on remuneration to senior
management and the recommendation from the nomination committee.

All documents to be treated at the general meeting, including the Company's
annual accounts of 2020, will be made available at the Company's website 
www.aquabiotechnology.com - http://www.aquabiotechnology.com. 

Due to the corona virus situation, the Company encourages the shareholders to
refrain from attending the general meeting in person and to give authorization
to vote the shares.

Shareholders who wish to attend the general meeting is requested to notify the
Company as set out in the notice within 4 June 2021 at 16:00 (CEST). In case of
attendance by proxy, the proxy form is requested submitted to be received by the
Company within the same date. 

For further information, please contact CEO Espen Kvale, telephone +47 9162
8092.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company's strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

This information was considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 of the Norwegian Securities Trading Act.

 

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

ABT Innkalling OGF 2021 Notice AGM 2021.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/578/768/ABT%20Innkalling%20OGF%20
2021%20Notice%20AGM%202021.pdf

ABT Paameldingsskjema og fullmakt OGF 2021 Registration Form and Proxy AGM
2021.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/578/769/ABT%20Paameldingsskjema%2
0og%20fullmakt%20OGF%202021%20Registration%20Form%20and%20Proxy%20AGM%202021.pdf

ABT Nomination commitee proposal and Statement and remuneration to executive
management.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/578/770/ABT%20Nomination%20commit
ee%20proposal%20and%20Statement%20and%20remuneration%20to%20executive%20manageme
nt.pdf